tofacitinib

Related by string. Tofacitinib * * *

Related by context. All words. (Click for frequent words.) 66 tasocitinib 65 figitumumab 64 axitinib 64 mipomersen 64 elotuzumab 64 ocrelizumab 63 sunitinib 63 darapladib 63 candesartan 63 vicriviroc 63 BAY #-# 63 pomalidomide 62 Mylotarg 62 lupus nephritis 62 eltrombopag 62 dimebon 62 baminercept 62 cabazitaxel 62 panitumumab Vectibix 62 tocilizumab 62 tanezumab 62 teriflunomide 62 rolofylline 61 HCV RESPOND 2 61 Targretin 61 phase IIb clinical 61 FTY# 61 REMICADE ® 61 levosimendan 61 ruboxistaurin 61 NATRECOR R 61 thalidomide Thalomid 61 motavizumab 61 fluvastatin 61 ipilimumab 61 TELINTRA 61 romiplostim 61 semagacestat 61 Dasatinib 61 vandetanib 61 LAF# 61 Viramidine 60 Phenoptin 60 phase IIa 60 Cimzia TM 60 JAK inhibitor 60 Rivaroxaban 60 Promacta 60 Mipomersen 60 ancrod 60 bicifadine 60 Atacand 60 NVA# 60 cangrelor 60 motesanib 60 GVAX 60 SRT# [003] 60 adalimumab Humira 60 Tarceva erlotinib 60 nilotinib 60 antithrombotic 60 dirucotide 60 RSD# oral 60 fostamatinib 60 iniparib 60 heterozygous FH 60 TBC# 60 cediranib 60 GSK# [002] 60 TORISEL 60 muraglitazar 59 riociguat 59 Avandia rosiglitazone 59 tafamidis 59 Aryplase 59 mRCC 59 midstage studies 59 oral antidiabetic agents 59 enzastaurin 59 vemurafenib 59 iclaprim 59 posaconazole 59 valsartan 59 olmesartan 59 sorafenib Nexavar 59 temsirolimus 59 midstage clinical 59 nalbuphine ER 59 risperidone Risperdal 59 DEB# 59 desvenlafaxine succinate 59 Amrubicin 59 vismodegib 59 cetuximab Erbitux 59 diabetic neuropathic pain 59 SCH # 59 lumiliximab 59 primary hypercholesterolemia 59 eritoran 59 midstage study 59 RoACTEMRA 59 visilizumab 59 mycophenolate mofetil 59 pazopanib 59 mapatumumab 59 blood thinner apixaban 59 RELOVAIR ™ 59 Reverset 59 Femara letrozole 59 severe hypercholesterolemia 59 olaparib 59 adalimumab 59 JANUMET 59 AGILECT R 59 phase IIb 59 Tofacitinib 59 raltegravir 59 ponatinib 59 PREZISTA r 59 dose cohorts 59 anacetrapib 59 TELCYTA 59 abiraterone 59 Jevtana 58 chlorambucil 58 Nexavar sorafenib 58 Teriflunomide 58 relapsing MS 58 apixaban 58 Tarceva TM 58 LymphoStat B 58 Aptivus 58 HCV SPRINT 58 aflibercept 58 TNF antagonist 58 midstage clinical trials 58 Ocrelizumab 58 lomitapide 58 donepezil 58 cladribine 58 daclizumab 58 panitumumab 58 pramlintide 58 rindopepimut 58 cilengitide 58 Actimmune ® 58 Tarceva 58 allopurinol 58 erlotinib Tarceva 58 Zometa zoledronic acid 58 PEG INTRON 58 divalproex sodium 58 torsemide ER 58 Canvaxin 58 clinical pharmacology studies 58 efalizumab 58 phase IIa clinical 58 oral methylnaltrexone 58 BRIM3 58 PROSTVAC TM 58 abiraterone acetate 58 glatiramer acetate 58 Genentech Rituxan 58 drug figitumumab 58 Dacogen injection 58 phase IIb study 58 lapatinib Tykerb 58 telcagepant 58 Phase Ib study 58 tolvaptan 58 ziprasidone Geodon 58 docetaxel chemotherapy 58 Vectibix 58 sunitinib malate 58 lintuzumab SGN 58 ximelagatran 58 aripiprazole Abilify 58 Accolate 58 Saxagliptin 58 dasatinib 58 oxymorphone ER 58 QTc prolongation 58 virologic failure 58 Tasigna nilotinib 58 Onbrez Breezhaler 58 Dapagliflozin 58 Arixtra 58 ATACAND 58 ACTOS 58 rNAPc2 58 glufosfamide 58 antibiotic Ketek 58 bifeprunox 58 midstage trials 58 lesinurad 58 aclidinium 58 metastatic renal cell carcinoma 58 tecarfarin 58 Sprycel dasatinib 58 ARCOXIA 58 leukemia AML 58 Golimumab 58 galiximab 58 Revlimid lenalidomide 58 antiplatelet agent 58 Pirfenidone 58 gefitinib Iressa 58 OvaRex ® MAb 58 TNF inhibitor 58 odanacatib 58 TMC# [001] 58 Actemra 58 decitabine 58 Hepsera 58 Crestor rosuvastatin 58 oxypurinol 58 azilsartan medoxomil 58 chronic myeloid leukemia CML 58 atrasentan 58 YONDELIS 58 interferon therapy 58 maraviroc 58 canakinumab 58 TNF inhibitors 58 PRT# 58 sorafenib 58 squalamine 58 phase III isavuconazole 57 6R BH4 57 ADHF 57 relapsed refractory multiple myeloma 57 interferon gamma 1b 57 Adentri 57 TACI Ig 57 pirfenidone 57 galantamine 57 pertuzumab 57 ACTEMRA 57 Vorapaxar 57 paliperidone palmitate 57 REMINYL ® 57 Zactima 57 dose regimens 57 metastatic HRPC 57 Torisel 57 dronedarone 57 uric acid lowering 57 PRIMO CABG 57 Corlux 57 paliperidone ER 57 SinuNase TM 57 β blockers 57 LY# [003] 57 docetaxel Taxotere ® 57 PegIntron 57 senicapoc 57 alogliptin 57 torcetrapib atorvastatin 57 peginterferon 57 COREG 57 Rituxan 57 natalizumab 57 inhibitor RG# 57 Eliquis 57 refractory gout 57 calcineurin inhibitors 57 mTOR inhibitor 57 INCB# [001] 57 Phase #/#a 57 midstage clinical trial 57 alemtuzumab 57 tenofovir emtricitabine 57 MNTX 57 Velcade bortezomib 57 INCB# [003] 57 Aflibercept 57 Starlix 57 Relovair 57 regorafenib 57 Rasagiline 57 APTIVUS 57 clazosentan 57 ISIS # 57 methylnaltrexone 57 Bronchitol 57 anidulafungin 57 clopidogrel Plavix 57 taranabant 57 VA# [002] 57 solanezumab 57 concomitant medications 57 Fludara 57 PROMACTA 57 relapsing remitting multiple sclerosis 57 DU #b 57 BARACLUDE R 57 antihypertensive drugs 57 crizotinib 57 indolent NHL 57 Xelox 57 phase IIb trial 57 enalapril 57 forodesine 57 hepatotoxicity 57 ALT flares 57 amrubicin 57 conventional antipsychotics 57 nitazoxanide 57 azacitidine 57 Phase #b/#a 57 COPAXONE R 57 Zarnestra 57 lorcaserin 57 beta2 agonist 57 DPP4 inhibitor 57 renal toxicity 57 ORENCIA R 57 coinfected patients 57 PRISTIQ 57 dosing regimens 57 sapacitabine 57 Zolinza 57 Fablyn 57 heavily pretreated 57 MK #B 57 Revlimid 57 eculizumab 57 DAPT 57 pioglitazone 57 vildagliptin 57 R sorafenib tablets 57 acyclovir Lauriad R 57 Asentar 57 lenalidomide Revlimid 57 PEGINTRON TM 57 Lu AA# 57 Nuvion 57 SJIA 57 atacicept 57 Heplisav 57 Kynapid 57 infliximab Remicade 57 Cloretazine 57 dexanabinol 57 Rasilez Tekturna 57 QVA# 57 Cimzia 57 Atrasentan 57 AVE# 57 experimental hepatitis C 57 HGS# 57 infliximab 57 oral vancomycin 57 Clolar 57 Celebrex celecoxib 57 Cerovive 57 montelukast 57 Sprycel 57 anakinra 57 standard chemotherapy regimen 57 Urocortin 2 57 rosuvastatin 57 CANCIDAS 57 lenalidomide Revlimid R 57 RhuDex 57 docetaxel Taxotere R 57 neratinib 57 metastatic CRC 57 adecatumumab 57 investigational therapies 57 EVIZON 57 lymphoma CTCL 57 placebo controlled studies 57 bosentan 56 SUTENT ® 56 Tolamba 56 sustained virologic response 56 antihypertensive therapy 56 apremilast 56 abacavir containing 56 carvedilol 56 Genasense 56 antiarrhythmic drug 56 APTIVUS r 56 bosutinib 56 Boceprevir 56 flecainide 56 INVEGA ® SUSTENNA ® 56 Sutent 56 Phase IIIb clinical 56 leukotriene receptor antagonists 56 anti TNF alpha 56 obatoclax 56 SUTENT 56 angioedema 56 perampanel 56 Bifeprunox 56 Uloric 56 Plicera 56 ribavirin RBV 56 NOXAFIL 56 lacosamide 56 insulin detemir 56 AZILECT 56 trastuzumab DM1 56 rufinamide 56 NP2 Enkephalin 56 rFVIIa 56 aclidinium bromide 56 tanespimycin 56 ambrisentan 56 weekly subcutaneous injections 56 TroVax 56 SPRYCEL ® 56 investigational monoclonal antibody 56 Afatinib 56 Noxafil 56 OHR/AVR# 56 teduglutide 56 investigational compound 56 antidiabetic therapy 56 peginesatide 56 investigational compounds 56 anti TNF 56 alvimopan 56 rheumatoid arthritis 56 sitaxsentan 56 haloperidol Haldol 56 PEG PAL 56 alvespimycin 56 ganetespib 56 Xinlay 56 HAART regimens 56 QAB# 56 Aptivus ® 56 CIMZIA TM certolizumab pegol 56 renal flares 56 placebo controlled clinical trials 56 Merck KGaA Erbitux 56 Apixaban 56 ELACYT 56 levetiracetam 56 lumiracoxib 56 glitazones 56 Tolvaptan 56 ribavirin therapy 56 gemifloxacin 56 prasugrel 56 AZT zidovudine Retrovir 56 vidofludimus 56 Myfortic 56 blood clot preventer 56 Phase Ib clinical 56 BRAF inhibitor 56 pradefovir 56 atypical antipsychotic 56 rilonacept 56 rivaroxaban 56 Ilaris 56 diabetes pills Januvia 56 GAMMAGARD 56 myeloproliferative disorders 56 registrational 56 Ambrisentan 56 Vernakalant 56 Tykerb 56 Sutent sunitinib 56 BCX# 56 Cladribine Tablets 56 PEG Interferon lambda 56 QT prolongation 56 lipid lowering therapies 56 hypomethylating agents 56 candesartan cilexetil 56 boceprevir 56 Neupro R 56 hepatic toxicity 56 tolerability profiles 56 tigecycline 56 bezafibrate 56 Actilon 56 GSK# [001] 56 bisoprolol 56 ularitide 56 Puricase 56 sorafenib tablets 56 Pivotal Phase III 56 selective COX 2 56 golimumab 56 abatacept 56 protease inhibitor PI 56 albinterferon alfa 2b 56 ZACTIMA 56 abacavir lamivudine 56 Tasimelteon 56 Alfimeprase 56 cannabinor 56 xanthine oxidase inhibitor 56 hepatitis C HCV 56 Telintra 56 telbivudine 56 compound INCB# 56 NYHA Class II 56 pulmonary arterial hypertension 56 GW# [003] 56 synthetic retinoid 56 tasisulam 56 Epivir 56 neuropsychiatric symptoms 56 Pegasys ® 56 etanercept 56 Alzhemed TM 56 CellCept 56 retinal vein occlusion 56 sirolimus 56 MAGE A3 ASCI 56 entecavir 56 almorexant 56 ritonavir boosted 56 PEGylated interferon beta 1a 56 Dimebon 56 TNF antagonists 56 neovascular AMD 56 Panzem R 56 boosted protease inhibitor 56 monotherapy 56 RRMS patients 56 MAP# 56 metastatic castration resistant 56 viral kinetics 56 PSN# [002] 56 intensive statin therapy 56 Sibutramine Cardiovascular Outcomes 56 olanzapine Zyprexa 56 MERLIN TIMI 56 virological failure 56 Omacetaxine 56 pimozide 56 Yervoy 56 eplerenone 56 MabThera Rituxan 56 REYATAZ R 56 perindopril 56 trastuzumab DM1 T DM1 56 etravirine 56 erlotinib Tarceva ® 56 Aromasin 56 liprotamase 56 XL# SAR# 56 Fibrillex TM 56 Allovectin 7 ® 56 elvitegravir 56 Phase IIb clinical trials 56 ATL/TV# 56 Contrave# 55 AZILECT R 55 idraparinux 55 diabetic macular edema 55 brivaracetam 55 STRIDE PD 55 Abiraterone acetate 55 celgosivir 55 tyrosine kinase inhibitor 55 antithrombotics 55 Zavesca 55 Phase 2b study 55 fingolimod 55 anti leukemic 55 immunosuppressant drug 55 antiplatelet therapy 55 phase Ib 55 Galida 55 Muraglitazar 55 IBS C 55 bazedoxifene 55 VaD 55 SAR# [004] 55 EMPHASIS HF trial 55 Ozarelix 55 casopitant 55 MYDICAR 55 Tocosol Paclitaxel 55 metastatic lung cancer 55 alfa 2a 55 neovascular diseases 55 Specifid 55 Paxil paroxetine 55 AEGR 55 afatinib 55 Betaferon ® 55 safinamide 55 placebo controlled Phase 55 anthracycline taxane 55 pegylated interferon alpha 55 ivabradine 55 beta blocker therapy 55 Hematide 55 Traficet EN 55 ASA# 55 DASISION 55 intermittent dosing 55 Diamyd ® 55 dalbavancin 55 beta interferons 55 recurrent glioblastoma multiforme 55 RISPERDAL ® CONSTA ® 55 proteasome inhibitor 55 UCB Cimzia 55 Ereska 55 Pegintron 55 bortezomib 55 RLAI 55 naproxen esomeprazole magnesium 55 metastatic colorectal cancer 55 tramiprosate ALZHEMED TM 55 fulvestrant 55 elacytarabine 55 investigational protease inhibitor 55 Certolizumab pegol 55 tremelimumab 55 atherothrombotic events 55 oral cladribine 55 superficial bladder cancer 55 valvulopathy 55 valopicitabine 55 carfilzomib 55 Clozaril 55 temozolomide 55 CRLX# 55 levetiracetam Keppra 55 ACZ# 55 TYZEKA 55 cetuximab Erbitux R 55 idiopathic thrombocytopenic purpura 55 pegylated interferon peg IFN 55 albiglutide 55 irbesartan 55 metformin sulfonylurea 55 genotypic resistance 55 Prezista 55 Trexima 55 QLT# 55 MabThera rituximab 55 Certolizumab 55 Arcalyst 55 Neulasta ® 55 VEGF Trap Eye 55 Arranon 55 Pemetrexed 55 amoxicillin clavulanate 55 OXi# 55 myelodysplastic syndrome MDS 55 QNEXA 55 Eraxis 55 DMARD 55 Fx #A 55 non metastatic osteosarcoma 55 Vandetanib 55 bardoxolone 55 MAXY alpha 55 bevacizumab Avastin 55 opioid induced bowel dysfunction 55 ranolazine 55 pegloticase 55 warfarin therapy 55 atorvastatin Lipitor 55 cilostazol 55 sitagliptin 55 trastuzumab Herceptin ® 55 ImClone Erbitux 55 tacrolimus ointment 55 STELARA TM 55 oral anticoagulants 55 ZOLINZA 55 MS relapses 55 CIMZIA ™ 55 receptor tyrosine kinase inhibitor 55 abatacept Orencia 55 placebo controlled clinical 55 VADT 55 follicular lymphoma FL 55 eosinophilic asthma 55 gefitinib 55 Tekamlo 55 PEARL SC 55 fibromyalgia syndrome 55 edoxaban 55 cholinesterase inhibitors 55 statin 55 cholinesterase inhibitor 55 Dalbavancin 55 pravastatin Pravachol 55 HQK 55 exenatide 55 Albuferon 55 diabetic kidney 55 non selective NSAIDs 55 TEAEs 55 CIMZIA TM 55 EndoTAG TM -1 55 Kuvan 55 pioglitazone HCl 55 atypical antipsychotic medication 55 MIRAPEX ER 55 voreloxin 55 sipuleucel T 55 Cimzia ® 55 HSCT 55 Cinquil 55 Engerix B 55 thienopyridines 55 rotigotine 55 INSPIRE Trial Phase III 55 oral rivaroxaban 55 Vertex telaprevir 55 Tygacil 55 Motavizumab 55 Northera 55 milligram dose 55 venlafaxine Effexor 55 mitoxantrone 55 APD# 55 ACTEMRA TM 55 pegylated interferon alfa 2a 55 direct thrombin inhibitors 55 sJIA 55 AIM HIGH 55 Phase IIb trials 55 deforolimus 55 Advexin 55 BARACLUDE ® 55 Campath alemtuzumab 55 nefazodone 55 investigational hepatitis C 55 velafermin 55 Humira adalimumab 55 Vectibix panitumumab 55 metastatic RCC 55 omalizumab 55 clinical trials 55 MGd 55 Maraviroc 55 Ventavis 55 Triapine 55 Milnacipran 55 statin medications 55 HAART regimen 55 Spiriva HandiHaler 55 Dacogen 55 CMV disease 55 budesonide foam 55 Potiga 55 HUMIRA 55 ofatumumab 55 Asmanex 55 lixisenatide 55 ExTRACT TIMI 55 Fibrillex 55 aleglitazar 55 anthracyclines taxanes 55 ZD# [001] 55 secondary efficacy endpoints 55 Cimzia R 55 vosaroxin 55 Genz # 55 quetiapine Seroquel 55 Ranexa 55 TREANDA 55 gadobutrol 55 Enbrel etanercept 55 hepatorenal syndrome 55 Phase 2a trial 55 prior chemotherapy regimens 55 NV1FGF 55 fidaxomicin 55 Cleviprex TM clevidipine 55 thromboembolic events 55 mg dose 55 mertansine 55 sunitinib Sutent 55 eprotirome 55 omecamtiv mecarbil 55 homozygous familial hypercholesterolemia 55 receptor inhibitor 55 intravenous bisphosphonates 55 metaglidasen 55 non nucleoside HCV 55 placebo controlled trials 55 paroxetine Seroxat 55 Flovent HFA 55 HoFH 55 rosuvastatin Crestor 55 antihypertensive medications 54 invasive candidiasis 54 Byetta exenatide 54 Phase 2b clinical trials 54 Celsentri Selzentry 54 #mg doses [002] 54 antithrombotic therapy 54 antiretroviral naïve 54 Laquinimod 54 Myelodysplastic Syndrome MDS 54 dabigatran etexilate 54 anticlotting drugs 54 Aurexis 54 Ceflatonin 54 paroxetine Paxil 54 CDP# 54 Valsartan 54 Zyflo 54 Epratuzumab 54 danoprevir 54 Safinamide 54 Temsirolimus 54 Androxal TM 54 zalutumumab 54 LEP ETU 54 Xanafide 54 TNF antagonist therapy 54 VEGF inhibitors 54 Phase 2b clinical 54 TREDAPTIVE 54 RAPTIVA 54 KRN# 54 Vaprisol 54 ragweed allergy 54 ustekinumab 54 Vidaza R 54 cinacalcet HCl 54 Aceon 54 Zytiga 54 nitrofurantoin 54 bendamustine 54 Selzentry 54 VEGF Trap 54 Carfilzomib 54 VIIBRYD 54 IRESSA 54 refractory acute myeloid 54 aliskiren 54 XGEVA 54 leflunomide 54 maximally tolerated lipid lowering 54 esomeprazole Nexium 54 Roche Actemra 54 AA Amyloidosis 54 Exanta 54 TKI therapy 54 heFH 54 postoperative ileus POI 54 orBec 54 Certriad 54 FOLOTYN ® 54 cardiotoxicity 54 hematologic parameters 54 Nexavar 54 fibrate 54 Gleevec imatinib 54 verapamil 54 Vicriviroc 54 guanfacine extended release 54 Phase III trials 54 mixed dyslipidemia 54 rALLy trial 54 Bonefos 54 Phase IIa clinical 54 Hydroxyurea 54 TYGACIL 54 Cariprazine 54 COU AA 54 Romiplostim 54 Gleevec imatinib mesylate 54 Doxil ® 54 refractory NSCLC 54 Onconase 54 either acutely decompensated 54 Amigal 54 glatiramer 54 chronic lymphocytic leukemia CLL 54 Prosaptide 54 talactoferrin 54 GRN# 54 acute decompensated heart 54 CA4P 54 selective modulator 54 refractory chronic lymphocytic 54 deferiprone 54 pimecrolimus 54 idiopathic pulmonary fibrosis IPF 54 protease inhibitor 54 AVASTIN 54 Catena ® 54 corticosteroid therapy 54 refractory CTCL 54 Innohep 54 paliperidone 54 telaprevir 54 ROTATEQ 54 ramelteon 54 myopathy rhabdomyolysis 54 heterozygous familial hypercholesterolemia 54 terlipressin 54 Betaferon R 54 PXD# 54 methotrexate 54 virologically 54 GRNCM1 54 oral ridaforolimus 54 angiogenesis inhibitor 54 peginterferon alfa 54 ridaforolimus 54 sodium thiosulfate STS 54 Actos pioglitazone 54 IV NSCLC 54 viral kinetic 54 ALN PCS 54 HIV HCV coinfected 54 Xarelto 54 disease modifying antirheumatic 54 Pegasys plus Copegus 54 febuxostat 54 multicenter placebo controlled 54 efficacy endpoints 54 phase IIIb 54 pain palliation 54 rilpivirine 54 perifosine 54 Spiriva 54 Neuvenge 54 Sutent sunitinib malate 54 gastrointestinal stromal tumor GIST 54 venous thromboembolic events 54 Vidaza azacitidine 54 ticagrelor 54 Torsades de Pointes 54 Axitinib 54 goserelin 54 glitazone 54 tolerability 54 ADVANCE PD 54 DMARD therapy 54 ibandronate 54 imatinib therapy 54 IV melanoma 54 GPR# agonist 54 Galvus 54 MMP inhibitors 54 antihypertensive agents 54 Phase III randomized controlled 54 MEVACOR 54 metastatic kidney 54 ELND# 54 peginterferon alpha 2a 54 FOLFIRI 54 RSD# 54 anticoagulant warfarin 54 donepezil Aricept 54 salmeterol fluticasone 54 CBLC# 54 arterial thrombosis 54 relapsed MM 54 SEROQUEL XR 54 COPAXONE ® 54 disease progression 54 symptomatic VTE 54 lasofoxifene 54 FOLPI 54 Evoltra ® 54 cancer mCRC 54 NSAID 54 including eniluracil ADH 54 imatinib Gleevec ® 54 metformin 54 statin therapy 54 Recentin 54 Alemtuzumab 54 Desmoteplase 54 Vitaxin 54 clevidipine 54 basiliximab 54 Iloperidone 54 Troxatyl 54 Omnitarg 54 cardiovascular morbidity 54 Velcade 54 torezolid phosphate 54 factor Xa inhibitor 54 diabetic gastroparesis 54 protease inhibitors 54 Enbrel Remicade 54 Treanda 54 R#/MEM # 54 FASLODEX 54 CLARITY study 54 zolmitriptan 54 Provacel 54 davalintide 54 teplizumab 54 Telavancin

Back to home page